Purpose To develop and validate a method for the simultaneous measurement of adenosine, guanosine, and inosine derived from mono (MP) and triphosphate (TP) forms in peripheral blood mononuclear cells (PBMCs), red blood cells (RBCs) and dried blood spots (DBS). Methods Solid phase extraction of cell lysates followed by dephosphorylation to molar equivalent nucleoside and LC-MS/MS quantification. Results The assay was linear for each of the three quantification ranges: 10-2000, 1.0-200 and 0.25-50 pmol/sample for adenosine, guanosine, and inosine, respectively. Intraassay (n = 6) and interassay (n = 18) precision (%CV) were within 1.7 to 16% while accuracy (%deviation) was within −11.5 to 14.7% for all three analytes. Nucleotide monophosphates were less concentrated than triphosphates (except for inosine) and levels in PBMCs were higher than RBCs for all three nucleotides (10, 55, and 5.6 fold for ATP, GTP and ITP, respectively). DBS samples had an average (SD) of −26% (22.6%) lower TP and 184% (173%) higher MP levels compared to paired RBC lysates, suggesting hydrolysis of the TP in DBS. Conclusion This method was accurate and precise for physiologically relevant concentrations of adenosine, guanosine and inosine nucleotides in mono-and triphosphate forms, providing a bioanalytical tool for quantitation of nucleotides for clinical studies. 
INTRODUCTION
The study of purines has been evolving since Scheele discovered uric acid in the renal calculus in 1776 (1) . It was a quarter of a century later that an assay to measure uric acid was developed by Garrod who correlated high levels of this byproduct with the occurrence of gout (2) . Gout, however, is only one of many diseases caused by complications from the misbalance of purine levels in the body. There are 14 different disorders resulting from inborn errors in purine and pyrimidine metabolism (3, 4) . Low expression of adenosine deaminase and purine nucleoside phosphorylase, for example, results in immunodeficiency caused by raised concentrations of deoxyadenosine and deoxyguanosine (5) (6) (7) . Recent studies have shown that adenosine and guanosine play important roles in the protection of the nervous system (8) and may also be involved in the regulation of cortisol or other hormones (9) . Anti-viral, anti-cancer and immunosuppressive therapies are commonly based on analogs of endogenous nucleobases. Because of this, many of the associated toxicities (i.e. anemia, weakened immune system) and efficacies (i.e. inhibition of cancerous and/or viral DNA) of these drugs occur by competing with, and in some cases altering, endogenous nucleotide pools in the body (10, 11) .
In order to measure endogenous nucleotides in vivo, it is necessary to develop sophisticated techniques for quantification of these bases in different cellular matrices. Several methods were previously developed to specifically measure adenosine and guanosine related nucleotides in red blood cells (RBCs) with HPLC coupled to ultravioletvisible and/or diode array detection (10, (12) (13) (14) (15) (16) (17) . The range of concentrations detected specifically for ATP and GTP was similar for all of these methods (~114 to 213 and~3.3 to 8.6 pmol/10 6 cells (10, 13, 16, 17) ). Methods that assayed other cell types, like peripheral blood mononuclear cells (PBMCs), found adenosine and guanosine nucleotide concentrations that were roughly 10 fold higher than RBCs (10, 13) . Newer methods utilize mass spectrometry as a more selective and sensitive detection method. Quantification has been performed in multiple matrices and for multiple nucleotides in these methods, (18) (19) (20) (21) however, most utilize direct analysis techniques where phosphate fractions are separated on an HPLC column using ion pairing based mobile phases. This separation method may cause ion suppression from the mobile phase and also affects the column chromatography for measuring other molecules with HPLC. The indirect method described in this work is advantageous for preventing ion suppression caused by ion pairing agents and allows the detection of monophosphate (MP), diphosphate (DP) and triphosphate (TP) fractions in the free base form. This is valuable because one calibration curve can be utilized and does not need to be made with the phosphorylated moieties for the measurement of clinical samples. Additionally, the chromatography is simplified and use of non-phosphorylated samples allows more accurate mass spectrometry detection since the analytes do not carry extra negative charge.
A sensitive method was developed and validated to measure MP and TP fractions of adenosine, guanosine and inosine in human cells. This is the first method to measure MP and TP forms of adenosine, guanosine and inosine simultaneously in several cell types. In particular, this method was used for PBMCs, RBCs and explores the possibility of dried blood spot (DBS) measurement as a more clinically affordable and simple sample type for future analysis. DBS measurement is useful in a clinical setting because of its ease and affordability and has been used recently for the quantification of adenosine and 2'deoxyadenosine for the purpose of identifying adenosine deaminase deficiency in infants (22) . As such, it is important to determine the feasibility of DBS as a matrix for the accurate measurement of endogenous nucleotides. Stability of these nucleotides at varying conditions as well as specificity and selectivity was assessed in addition to the accuracy and precision of this method.
MATERIALS AND METHODS

Chemicals and Supplies
Adenosine, Adenosine Monophosphate (AMP), Adenosine triphosphate (ATP), Guanosine, Guanosine monophosphate (GMP), guanosine triphosphate (GTP), Inosine, Inosine monophosphate (IMP), and Inosine triphosphate (ITP) were purchased from Sigma Aldrich, St. Louis, MO; isotopic internal standards for each, (Ribose 13 C 5 ) were from Cambridge Isotope Laboratories, Andover, MA.
Analytical grade reagents were purchased from Fisher Scientific, Fairlawn, NJ, (acetonitrile, methanol, formic acid, potassium chloride, phosphoric acid, and ammonium hydroxide) as well as Whatman® 903 DBS cards, bags and desiccant for DBS preparation and storage. Ammonium acetate 5 M solution was purchased from Ambion® and alkaline phosphatase was purchased from Sigma Aldrich, St. Louis. Ultrapure (UP) water was prepared in house from deionized water with a Barnstead Nanopure System (Thermo Fisher Scientific, Waltham, MA). Other supplies included Waters Sep-Pak Accell Plus QMA Cartridge, 3 cc (500 mg) (Waters Corporation, Milford, MA) and Varian Bond-Elut LRC Phenylboronic Acid (PBA) Cartridge 100 mg/10 mL (Agilent, Santa Clara, CA). Blood products for lysed cellular matrix were obtained from Bonfils, Denver CO. Cell preparation tubes (CPT) and dipotassium EDTA tubes were purchased from Becton, Dickinson and Company, Franklin Lakes, NJ.
Sample Collection and Matrix Preparation
Clinical samples (PBMCs, RBCs and DBS) were obtained from 36 hepatitis C-infected individuals participating in an IRB-approved study of ribavirin (RBV) pharmacokinetics (23) . All patients provided written informed consent. Whole blood was drawn into EDTA or cell preparation tubes prior to centrifugation and separation of the different cell types. Cells (RBCs and PBMCs) were counted using the Countess™ automated cell counter (Thermo Fisher Scientific). DBS were spotted on Whatman® 903 cards (followed by 2 h drying prior to storage) from EDTA whole blood before separation of RBCs and PBMCs. Cells were lysed and DBS extracted in 70:30 methanol:water and stored at −70°C prior to analysis.
Sample Extraction
For extraction, 70:30 lysates are added to a QMA anion exchange cartridge to separate MP (5 mL of 75 mM KCl), DP (7 mL of 90 mM KCl) and TP (2 mL of 1 M KCl) fractions using a potassium chloride salt gradient. The resulting separated fractions were then dephosphorylated to molar equivalent parent adenosine, guanosine and inosine with excess alkaline phosphatase for 10 min at 37°C followed by addition of internal standard (20 μL), desalting and concentration with PBA solid phase extraction. The latter consisted of several steps. First, the PBA cartridge was activated according to product specifications. Second, the QMA fractions were added to the cartridge followed by 100×g centrifugation. Washes consisted of 2 × 1 mL of 250 mM ammonium acetate followed by 2 × 1 mL of methanol. Analytes were then eluted with 20% formic acid in methanol solution, dried down and reconstituted in UP-water followed by injection on the LC-MS/MS system. Additional details on the sample preparation and extraction can be found in previous publications (24, 25) .
Instrumentation
MS-MS detection of the analytes and their respective internal standards was accomplished on a Thermo Scientific TSQ Vantage® triple quadrupole mass spectrometer coupled with a Thermo Scientific Accela 1250® pump and CTC Analytics HTC PAL® autosampler. The mobile phase was aqueous with 4% acetonitrile and 0.1% formic acid pumped at a flow rate of 200 μL/min. Chromatographic separation was accomplished with Develosil C 30 Reversed-Phase-Aqueous, 140 Å, 150-2.0 mm, 3 μm particle size column purchased from Phenomenex (Torrance, CA). Adenosine, guanosine and inosine analysis was operated in ESI + and the analytes SRM [precursor/product] + transitions (m/z) were detected as described in Table I . The adenosine + 1 m/z transition was used for detection of adenosine to avoid signal saturation at the upper range of quantification.
Standard, Quality Control and Internal Standard (IS) Preparation
Triphosphate stocks from reference powder were prepared in UP-water to approximately 1 mg/mL for ATP, GTP and ITP. Prior to dilution and combination into a working stock for preparing standards (STDs) and quality controls (QCs), purity and potency was determined for each analyte according to a previously presented method (26) QCs were also prepared from PS2 at four levels: lower limit of quantitation: LLOQ, low: QL, medium: QM and high: QH. For each analyte, the concentration for QL is three times the LLOQ, while QH is 80% of the upper limit of quantification. Specific concentrations of QCs for ATP, GTP and ITP are detailed in Table II . Isotopic, internal standard (IS) was prepared at a combined concentration of 1.25 pmol/μL from 1 mg/mL stocks and stored at 4°C. 
Determination of Accuracy and Precision
Accuracy was determined by comparing the mean response from each validation sample (n = 6 per QC level, per analyte) to the theoretical concentration for each level and is expressed as % deviation (%dev). Precision was calculated using the coefficient of variance (%CV) for the replicate analysis. Both accuracy and precision were determined for three separate analytical runs and within run (intraassay, n = 6) and between run (interassay, n = 18) calculations were assessed. Passing criteria were ±15% of nominal concentration for QL, Intraassay accuracy (%Dev)(N = 6) −3.2 to 0.5 −3.6 to 3.6 −11.5 to −2.9
Intraassay precision (%CV) (n = 6) 2.2 to 3.0 1.8 to 13. Intraassay precision (%CV) (n = 6) 
Matrix Effect, Recovery and Process Efficiency
Matrix effect (ME), recovery and process efficiency (PE) were assessed for TP samples only. Since ATP, GTP and ITP constitute the matrix itself, it was necessary to utilize stable labeled IS as the Banalyte^to determine these parameters. Five different lots of blank RBC were subjected to QMA extraction for each of the spiked (set 2) and extracted (set 3) samples for low (5.0 pmol/sample) and high (1600 pmol/sample) concentrations. Spiked samples had IS solution added after final elution from the PBA step while extracted samples had IS added prior to PBA extraction. Neat samples (set 1) were prepared by adding 20 μL of the respective IS concentration into 80 μL of UP-water followed by injection onto the MS system. Peak area responses were used to determine each parameter. ME was calculated by comparing mean peak area response of set 2 to set 1 (set 2/set 1 × 100), recovery (from the PBA extraction) was determined by comparing mean peak area response of set 3 to set 2 (set 3/set 2 × 100), and PE was determined by comparing mean peak area response of set 3 to set 1 (set 3/ set 1 × 100).
Conditional Stability Assessment
Several conditional stability experiments were performed: freeze/thaw, room temperature and extracted sample stability. Accuracy and precision were determined for triplicate treated and control samples and acceptance criteria were ±15% for both accuracy and precision determinations for all stability experiments. Freeze/Thaw stability in lysed intracellular matrix was assessed by allowing QL and QH QC samples to undergo three freeze/thaw cycles from −70°C. Thawing occurred for up to 2 h prior to extraction for each cycle. Samples were run in triplicate, and the mean response was compared to the nominal concentration for QL and QH and also compared to fresh triplicate QL and QH controls that did not undergo treatment conditions. Room temperature (RT) stability in 70% methanol was assessed by removing QL and QH samples from −70°C and allowing a thaw time of 60 and 144 h at room temperature. The QL and QH were analyzed in triplicate and mean response was compared to both nominal and mean response from freshly prepared QL and QH that were not subjected to the test condition.
Extracted sample stability was assessed by retaining six replicate QL and QH samples at RT after extraction and analysis for re-injection 144 h later. Mean response of the reinjected samples was compared to both nominal concentration and mean response from their initial injection.
VALIDATION RESULTS
Accuracy and Precision
The STD concentrations were back calculated using a weighted (1/concentration) quadratic regression curve. The experimental mean of the three runs was compared against the theoretical concentration for accuracy and was within ±8.4% for all STDs passing acceptance criteria. Overall, the %CV for each validation run was ≤9.4% and the average r 2 values were ≥0.9995 for all three analytes. A summary for individual interassay accuracy and precision ranges for each analyte is shown in Table II . It should be noted that a contamination peak was present in the blanks that interfered with quantification of ITP. The lowest ITP STD (0.25 pmol/sample) for each of the validation runs was therefore invalid indicating that the next lowest STD (0.625 pmol/sample) is the method LLOQ. Because of this, the reported accuracy and precision values of the calibration curve do not include the ITP STD at 0.25 pmol/sample, though the curve remained linear when it was included.
Mean intraassay and interssay data for ATP, GTP and ITP are presented in Table II . Intraassay accuracy for the QCs was −3.2 to 7.5%, −3.6 to 14.7% and −11.5 to 13.2% for ATP, GTP and ITP, respectively. Intraassay precision for all QC levels including the LLOQ was 0.9 to 7.1%, 1.2 to 16.0%, and 1.1 to 14.7% for ATP, GTP and ITP, respectively. Overall interassay precision for all analytes and QC levels was ≤15.0% and interassay accuracy was between −8.6 and 13.2%. The second validation run had 2/6 LLOQ fail high for GTP with one testing as a statistically significant outlier according to Grubb's outlier test (GraphPad QuickCalcs). These failures were most likely due to sample contamination from environmental factors as is described in the BDiscussion^section and so the outlier was not included in the accuracy and precision calculations. The average blank-IS response compared to the lowest STD (representative of the LLOQ for the extraction) are also reported in Table II . A typical chromatogram at the LLOQ level with a blank-IS sample overlay for each analyte is shown in Fig. 1a -c.
Matrix Effect (ME), Recovery, Process Efficiency (PE)
Adenosine, guanosine and inosine IS were prepared at high (1600 pmol/sample) and low (5.0 pmol/sample) concentrations in lysed cellular matrix that underwent the QMA isolation process. Compared to guanosine and inosine, adenosine IS had a larger suppression of signal due to matrix with a 78%/75% response for low/high concentrations. Guanosine and inosine IS had similar ME to each other at low/high of 88%/84% and 88%/87%, respectively. These data suggest a minimal suppressive effect of the matrix on the stable labeled IS version of the analytes. When comparing the slopes of each lot (peak area vs expected concentration) for the low and high sample, the %difference was −10.7 to 9.7% for all analytes. Recovery for stable labeled adenosine, guanosine and inosine for low/high IS levels was 73%/76%, 78%/74% and 66%/70%, respectively. This experiment shows that recoveries were similar between analytes and consistent between the low /high concentration levels. The mean PE for each analyte at low/high levels was 57%/57%, 69%/ 63%, and 58%/60% for adenosine, guanosine and inosine stable labeled IS, respectively. In general, the method provides process efficiencies that are all above 50% and have overall consistent PE between concentration levels.
Thaw/Thaw
All analytes were stable throughout the freeze/thaw test conditions. The %CV for all treated samples was ≤6.7% for QL and ≤1.8% for QH for all analytes. The %dev from control and nominal were within ±9.3% for QL and ±3.0% for QH showing all data are well within acceptance criteria for stability.
Conditional Stability: Room Temperature (RT)
ATP, GTP and ITP were stable in 70% methanol for 144 h for QH samples. The %CV was ≤5.1 for QL and ≤4.4 for QH while the % difference compared to untreated and nominal were within ±20.6 (GTP failed low compared to control while others remained within acceptance criteria) for QL and ±3.7 for QH. This suggested that 144 h may be too long at RT for lower concentrations, specifically for GTP. Because of this, another experiment was performed with the treatment at RT being only 60 h. This experiment gave a %dev at −16.0 for GTP at the QL level compared to control, which is still not within the acceptable criteria. These data suggest that samples should not remain at RT for longer than 2 h (based on the freeze/thaw experiments) and should be analyzed as soon as possible after removing from storage.
Conditional Stability: Extracted Stability
Extracted QL and QH (n = 6) samples (parent nucleosides re-constituted in UP-water after final PBA concentration) were left at RT for 144 h after analysis followed by reinjection and comparison to the initial response as well as nominal values. The %CV for all treated samples was ≤2.8% for QL and ≤2.4% for QH. The %dev compared to initial and nominal values was within ±4.0% for QL and ±2.1% for QH showing that samples are stable for up to 6 days post extraction. Although samples should not remain in 70:30 for longer than 2 h at room temperature prior to extraction (Conditional Stability: Room Temperature (RT) section), the UP-water that samples are retained in prior to injection onto the LC-MS/MS is a different matrix and therefore may not have the same effect on stability. All conditional stability results are shown in Table III for each individual analyte.
Carryover and Crosstalk Evaluation
Adenosine, guanosine and inosine cross talk evaluation showed no response from the respective IS when STD A was injected without IS present. Additionally, no significant cross talk response in the parent window was evident after the IS-only sample was injected. Carryover was assessed by injecting a blank water sample after STD A. There was no significant detection of adenosine, guanosine or inosine from this water injection indicating no significant carryover effect. In addition to analyzing the TP fraction (2 mL) obtained from the QMA procedure, it is also possible to quantify the MP fraction (5 mL) as well as the DP fraction (7 mL). This is simple for this particular assay because the Bond-Elut PBA cartridge can hold up to 10 mL of liquid and use of stable labeled IS should account for any difference in recovery of these samples compared to the TP fraction. Because the DP fraction is fleeting in the phosphorylation process (i.e. not the rate limiting step for equilibration to the TP form) and is therefore physiologically less relevant, this work focused on measurement of the MP and TP fractions only. To compare MP vs TP in vivo, 36 patient samples collected at day 1 of RBV treatment (2 h post dose) were used to quantify paired MP and TP from PBMC fractions. Figure 2 shows the difference in levels of MP and TP for adenosine, guanosine and inosine, respectively. PBMC mean (SD) MP fractions were 150 (108), 14.1 (8.5) and 30.6 (25.9) while TP fractions were 1303 (495), 264 (83) and 1.5 (0.10) pmol/10 6 cells for adenosine, guanosine and inosine, respectively. For both ATP and GTP these levels were comparable to literature values (10,13), but AMP and GMP levels were significantly higher (10 to 25 fold) which may be due either to the differing sensitivity of the methods (UV detection vs MS/MS) or a difference in the processing or extracting of cells.
RBC, PBMC and DBS
Some of the most common sample types collected for pharmacokinetic studies include RBCs, PBMCs, and more recently, DBS. To assess differences in these matrices for quantification of ATP, GTP and ITP, the same 36 patient samples were utilized (Fig. 3) . The mean (SD) RBC concentrations were 128 (20.6), 4.8 (1.2) and 0.27 (0.17) compared to PBMCs corresponding to 10, 55, and 5.6 fold lower concentrations for ATP, GTP and ITP, respectively. Although the levels differ in these two matrices, the assay range allows simultaneous quantification of all analytes in both cell types.
For DBS, paired analysis of RBC lysate and DBS samples were analyzed in five subjects at six different treatment time points at either day 1 or steady state. Both the DBS and RBC lysates were stored at −70°C for 815-929 days prior to this analysis. The pmol/10 6 cells results for MP and TP for both matrices are reported in Table IVa (25, 27) . Briefly, the pmol/punch result is divided by the paired pmol/10 6 cells result from RBC lysate to yield the approximate (within 20%) amount of cells in a DBS punch (25) . Average (SD) TP DBS samples for all analytes were −26% (22.6) lower in response compared to RBC lysates, while MP were 184% (173) higher compared to RBC. This result was unexpected considering nucleoside analogs have been reported to have long term stability in DBS in −70°C storage conditions (28, 29) . There is likely a stability issue with endogenous nucleotides in DBS samples during the drying and storing process that needs to be evaluated if this matrix is to be useful for accurate quantification of endogenous nucleotides.
DISCUSSION
An assay for the measurement of TP and MP fractions of adenosine, guanosine and inosine was developed and validated. The method utilizes cellular lysate from different cell types, which increases applicability in clinical studies. The different levels seen in PBMCs vs RBCs are to be expected since PBMCs are nucleated cells and have enzymes that conduct de-novo nucleotide synthesis whereas RBCs only use salvage pathways. Also, RBC do not produce DNA or RNA but use nucleotides as an energy source for the cell itself. As such, there is less need for high concentrations of these molecules and so the quantities are lower compared to PBMCs. Additionally, the MP is the rate limiting step to become the TP, and higher TP is favored when nucleotide pools are at equilibrium (23, 30) . The exception to this would be IMP in PBMCs since it is an important molecule for the production of other nucleotides via the de novo synthesis pathway in nucleated cells.
It is important to note that these nucleotides are found primarily in cells because plasma contains phosphatases that convert nucleotides back into the parent form. Additionally, nucleotides are typically dephosphorylated prior to being able to exit the cell and so most extra-cellular purines are in the parent form. This assay eliminated any possible contamination from plasma concentrations of these parent purines because the initial strong ion exchange process does not allow parent forms to interact with the column packing. Therefore, even if there were some plasma left in intracellular samples, particularly for DBS where plasma is a component of the matrix, this would not contribute to the final analysis since it would be washed out prior to desalting/concentration and LC-MS/MS injection.
The application of this method to the DBS matrix provided useful information on the stability of these nucleotides. As mentioned earlier, DBS has been used for the measurement of many endogenous biomarkers including nucleotides, but stability of this matrix has not been thoroughly evaluated (22, 31, 32) . Other studies that have measured nucleotide pools in RBC samples have reported that immediate processing is a necessity for accurate results (17, 33) . Both the RBCs and DBS samples reported here were stored at −70°C for 815-929 days prior to this analysis, but DBS appeared to have a breakdown of TP to the MP compared to RBCs. One contribution to this instability may be that blood is not immediately dried on the paper prior to storage and remains at RT to dry for up to 4 h prior to storage. Therefore, it may be possible that enzymes are continuing to act in cells during the drying period where the enzymes are stopped immediately in RBCs that are lysed directly upon processing.
There are some limitations that should be considered for this method. First, it is important to note that ATP, GTP and ITP are endogenous substances that may be found in the general environment in bacteria, dust, or hair and skin. Because of this, the environment must be more thoroughly regulated for this assay. Several steps were taken to address this issue. 1) Glassware was washed thoroughly with UP-water prior to making solutions or prep stocks 2) Solutions of KCl and 250 mM ammonium acetate were prepared fresh within 1 week for all validation runs while enzyme solution was mixed immediately prior to each extraction 3) Enzyme diluent was prepared and frozen in aliquots prior to use 4) All pipets and secondary storage containers for buffers were sterile, disposable and new for each extraction to avoid any further sources for contamination. Additionally, a blank and blank plus IS sample were extracted through both QMA and PBA procedures in order to determine baseline contamination resulting from the assay process itself. The LLOQ was adjusted to the next calibration level according to whether the blank-IS response was >20% of the LLOQ response. This resulted in some analytes (specifically IMP/ITP) having a calibration curve with seven levels instead of eight as explained in the results.
This assay is sensitive, but the issue of potential contamination at the lower end of quantification may not allow consistent results at the LLOQ level of GMP/GTP or IMP/ITP. Specifically, for IMP/ITP the method LLOQ level was determined to be 0.625 pmol/10 6 cells based on the low signal of this analyte resulting in contamination issues at the LLOQ (0.25 pmol/10 6 cells) level. Because ITP concentrations are relatively low in RBCs, the issue of inconsistent quantification at the LLOQ could be more pronounced. More RBCs could be analyzed to increase sensitivity, but results would then be above the limit of quantification for ATP and GTP when assaying more than 10 × 10 6 cells. However, for all validation runs the adjusted LLOQ was still relatively sensitive at 0.625 pmol/sample; a lower amount than other methods published for the measurement of inosine or its IMP metabolite (17, 34) .
Additionally, because ITP is not incorporated into RNA or DNA, previous methods have not, to our knowledge, attempted to quantify this nucleotide. Nevertheless, it is an important anabolite for biological and pharmacological studies such as RBV-induced anemia (35) . The lowest STD passed for all GMP/GTP validation runs, but there was some potential contamination noted in the second validation run with the LLOQ samples. However, the LLOQ level did not appear to be a physiologically relevant concentration. All clinical samples analyzed for the guanosine component were well-above the LLOQ of 1.0 pmol/sample in both RBCs (range 5.96 to 44.6 pmol/sample) and PBMCs (range 2.16 to 101 pmol/sample).
The experiments for understanding the effect of the matrix on the isotopically labeled versions of these analytes were important for demonstrating the reproducibility of the method. However, ME is less relevant for this method because this assay utilized stable-labeled IS for quantification. Therefore, the matrix would equally affect the analyte and the IS and would be accounted for by using the ratio (analyte/IS) for calculation of concentrations.
CONCLUSION
An accurate and precise method was developed to measure the TP and MP moieties of adenosine, guanosine and inosine in RBCs and PBMCs at physiologically relevant concentrations of all analytes. The method was selective and specific and was reasonably stable in regards to freeze/thaw cycles and extracted stability. It is of note that samples should not remain at room temperature for longer than 2 h prior to extraction, that environmental contamination must be taken into account for accurate results and that DBS needs further stability evaluation for use in measuring these nucleotides.
